Literature DB >> 29407155

Electrospun membranes of PELCL/PCL-REDV loading with miRNA-126 for enhancement of vascular endothelial cell adhesion and proliferation.

Fang Zhou1, Meiling Wen1, Peiqiong Zhou1, Yunhui Zhao1, Xiaoling Jia2, Yubo Fan3, Xiaoyan Yuan4.   

Abstract

Surface modification for rapid endothelialization of vascular biomaterials is known as an important way to prevent thrombosis and intimal hyperplasia. Moreover, therapeutical manipulation of microRNAs (miRNAs) expression via local delivery of miRNA mimics or inhibitors by electrospun ultrafine fibers has demonstrated the promise in tissue regeneration. In this work, a dual-functional electrospun membrane was developed by combining Arg-Glu-Asp-Val (REDV) peptide-modification of the fiber surface to enhance vascular endothelial cell (VEC) adhesion and encapsulation of miRNA-126 (miR-126) complexes in the electrospun fibers to accelerate VEC proliferation. The electrospun membranes were specially prepared by emulsion electrospinning of poly(ethylene glycol)-b-poly(l-lactide-co-ε-caprolactone) (PELCL) and REDV-terminated polycaprolactone (PCL) (50/50 mass ratio), in which miR-126 was encapsulated via REDV peptide-modified trimethyl chitosan-g-poly(ethylene glycol). By introduction of REDV-terminated PCL with lower molecular weight, the obtained electrospun fibers could be modified by REDV on their surface, and also achieve a relatively fast release profile of miR-126 in favor of VEC proliferation. Results of direct seeding VECs on the electrospun membranes indicated the enhanced cell adhesion and proliferation. The combination of REDV peptide-modification of the electrospun fibrous membranes and controllable miRNA release may provide a synergistic strategy of surface guidance and biochemical signals to support and modulate VECs for vascular tissue regeneration.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electrospun membranes; PELCL; REDV peptide; Vascular endothelial cells; miRNA-126

Mesh:

Substances:

Year:  2017        PMID: 29407155     DOI: 10.1016/j.msec.2017.12.005

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

Review 1.  Electrospun-Fibrous-Architecture-Mediated Non-Viral Gene Therapy Drug Delivery in Regenerative Medicine.

Authors:  Elena Cojocaru; Jana Ghitman; Raluca Stan
Journal:  Polymers (Basel)       Date:  2022-06-29       Impact factor: 4.967

2.  Effect of tourmaline nanoparticles on the anticoagulation and cytotoxicity of poly(l-lactide-co-caprolactone) electrospun fibrous membranes.

Authors:  Tianyu Zhao; Hong Zhang; Pan Li; Jinsheng Liang
Journal:  RSC Adv       Date:  2019-01-04       Impact factor: 4.036

3.  Combinatorial functionalization with bisurea-peptides and antifouling bisurea additives of a supramolecular elastomeric biomaterial.

Authors:  Bastiaan D Ippel; Boris Arts; Henk M Keizer; Patricia Y W Dankers
Journal:  J Polym Sci B Polym Phys       Date:  2019-12-03

4.  Superhydrophilic Polyurethane/Polydopamine Nanofibrous Materials Enhancing Cell Adhesion for Application in Tissue Engineering.

Authors:  Kamil Kopeć; Michał Wojasiński; Tomasz Ciach
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

Review 5.  Nature-Derived and Synthetic Additives to poly(ɛ-Caprolactone) Nanofibrous Systems for Biomedicine; an Updated Overview.

Authors:  Shahin Homaeigohar; Aldo R Boccaccini
Journal:  Front Chem       Date:  2022-01-19       Impact factor: 5.221

6.  Vascular Polyurethane Prostheses Modified with a Bioactive Coating-Physicochemical, Mechanical and Biological Properties.

Authors:  Aleksandra Kuźmińska; Aleksandra Wojciechowska; Beata A Butruk-Raszeja
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 7.  Proteins and Peptides as Important Modifiers of the Polymer Scaffolds for Tissue Engineering Applications-A Review.

Authors:  Katarzyna Klimek; Grazyna Ginalska
Journal:  Polymers (Basel)       Date:  2020-04-06       Impact factor: 4.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.